Skip to content

Transcutaneous electrical nerve stimulation and diathermy microwave effects in the menstrual cramps

Transcutaneous electrical nerve stimulation and diathermy microwave effects in the primary dysmenorrhea: placebo-controlled clinical trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5qkck4
Enrollment
Unknown
Registered
2016-03-16
Start date
2016-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dismenorrhea

Interventions

Diathermy microwave and transcutaneous electrical nerve stimulation application in the infra-abdominal region. Eighty-eight women will selected and divided into 4 groups: GI (n:22) = diathermy microwa
GII (n:22) = diathermy microwave off (20 minutes) and transcutaneous electrical nerve stimulation sham (30 minutes)
GIII (n:22) = diathermy microwave sham (20 minutes)and transcutaneous electrical nerve stimulation connected (30 minutes)
GIV (n:22) = diathermy microwave sham (20 minutes)and transcutaneous electrical nerve stimulation sham (30 minutes). Everybody will received only one intervention.
Device
SP8.473.654.412.072.155.314

Sponsors

Universidade Cidade de São Paulo
Lead Sponsor
Universidade Cidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: Health women; 18 to 44 years; no previous pregnancy; no physical activity; body mass index <29.9 kg/m²; and had regular menstrual cycles, mild to moderate or severe menstrual cramps.

Exclusion criteria

Exclusion criteria: hormonal contraceptives use; anti-inflammatory and/or analgesics for the treatment of menstrual cramps or any dysfunction; diabetes; rheumatic arthritis; gynecological diseases; presence of malignant or benign tumor; metal implants; cardiac diseases; pacemaker use; decreased or absence of sensitivity in the abdominal region; and epilepsy.

Design outcomes

Primary

MeasureTime frame
Mean difference of 2 points in Visual Numerical Scale of pain between the actives's group.

Secondary

MeasureTime frame
Visual Numeric Scale pain on the day following treatment.

Countries

Brazil

Contacts

Public ContactAline Fernanda Machado

UNICID Universidade Cidade de São Paulo

lifpm@yahoo.com.br+5511999390802

Outcome results

None listed

Source: REBEC (via WHO ICTRP)